Publicaciones en las que colabora con José Luis Vicario Moreno (43)

2024

  1. Centromeric AA motif in KIR as an optimal surrogate marker for precision definition of alloimmune reproductive failure

    Scientific Reports, Vol. 14, Núm. 1

2022

  1. Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases

    Journal of Clinical Medicine Research, Vol. 14, Núm. 8, pp. 309-314

2016

  1. Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial

    Transplant Infectious Disease, Vol. 18, Núm. 6, pp. 832-843

  2. Report From the First and Second Spanish Killer Immunoglobulin-Like Receptor Genotyping Workshops: External Quality Control for Natural Killer Alloreactive Donor Selection in Haploidentical Stem Cell Transplantation

    Transplantation Proceedings

2014

  1. Informe del Taller Ibérico de Histocompatibilidad 2013. Componente de análisis de situación de procedimiento de pruebas cruzadas en guardias de trasplante de órganos

    Inmunologia, Vol. 33, Núm. 1, pp. 27-33

  2. Narcolepsy with cataplexy and comorbid immunopathological diseases

    Journal of Sleep Research, Vol. 23, Núm. 4, pp. 414-419

2013

  1. Flow cytometry analysis with a new FITC-conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1-infected patients

    HIV Clinical Trials, Vol. 14, Núm. 4, pp. 160-164

2012

  1. Informe del Taller Ibérico de Histocompatibilidad 2012. Componente de estandarización de resultados de anticuerpos anti-HLA mediante ensayo en fase sólida

    Inmunologia

2008

  1. HLA genes of Aleutian Islanders living between Alaska (USA) and Kamchatka (Russia) suggest a possible southern Siberia origin

    Molecular Immunology, Vol. 45, Núm. 4, pp. 1018-1026

1996

  1. Frequencies of hla-a24 and hla-dr4-dq8 are increased and that of hla-b blank is decreased in chronic toxic oil syndrome

    International Journal of Immunogenetics, Vol. 23, Núm. 3, pp. 211-219

1993

  1. A decrease in the estimated frequency of the extended HLA haplotype B18 CF130 DR3 DQw2 is common to non-insulin-dependent diabetes, juvenile rheumatoid arthritis, and Berger's disease

    Experientia, Vol. 49, Núm. 6-7, pp. 553-556

  2. Differential contribution of C4 and HLA-DQ genes to systemic lupus erythematosus susceptibility

    Human Genetics, Vol. 91, Núm. 6, pp. 579-584

  3. HLA class I, class II, and class III antigen sharing is not found in couples with unexplained infertility

    International Journal of Fertility, Vol. 38, Núm. 5, pp. 280-288

1992

  1. Combined total deficiency of C7 and C4B with systemic lupus erythematosus (SLE)

    Clinical & Experimental Immunology, Vol. 87, Núm. 3, pp. 410-414

  2. Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as Type 11 (insulin-dependent)diabetes mellitus predictive risk markers in the Spanish population

    Diabetologia: Clinical and Experimental Diabetes and Metabolism, Vol. 35, Núm. 5, pp. 475-481

1991

  1. C4 Chido 3 and 6 Distinguish Two Diabetogenic Haplotypes: HLA-B49,SC01,DR4,DQw8 and B8,SC01,DR3,DQw2

    Immunobiology, Vol. 183, Núm. 1-2, pp. 12-22

  2. Exclusive HLA-DQ factors do not explain susceptibility to insulin-dependent diabetes

    Human Immunology, Vol. 31, Núm. 2, pp. 134-138

  3. Exon-2 nucleotide sequences, polymorphism and haplotype distribution of a new HLA-DRB gene: HLA-DRBσ

    Molecular Immunology, Vol. 28, Núm. 4-5, pp. 533-543

  4. Factores inmunológicos y de predisposición genética en la enfermedad por ingestión de aceite adulterado

    Factores inmunológicos y de predisposición genética en la enfermedad por ingestión de aceite adulterado

  5. Familial incidence of C3 nephritis factor

    Nephron, Vol. 59, Núm. 2, pp. 261-265